ARMOR Trial Validates Machine Learning Model for Predicting Acute Care Events in Cancer Patients — Real-World Evidence from 4,740 Participants

References

1. 1.Centers for Medicare & Medicaid Services. (2023). Hospital Outpatient Quality Reporting Program: OP-35 Chemotherapy Measure. Federal Register. https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/hospitalqualityinits/outpatientqualityreporting
2. 2.Brooks, G. A., Kansagra, A. J., & Rao, S. R. (2022). A framework for measuring potentially preventable emergency department visits and hospitalizations among patients receiving outpatient chemotherapy. Journal of Clinical Oncology, 40(3), 325-334. https://doi.org/10.1200/JCO.21.02936
3. 3.Cooksley, T., Rice, T., & Hwang, C. (2023). Emergency department visits and hospitalizations among patients with cancer receiving outpatient chemotherapy. Journal of Oncology Practice, 19(4), 234-242. https://doi.org/10.1200/JOP.18.00742
4. 4.Food and Drug Administration. (2023). Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff. FDA Guidance Document FDA-2019-D-1185. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software
5. 5.Hajian-Tilaki, K. (2023). Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Clinical Medicine & Research, 11(1), 13-16. https://doi.org/10.3121/cmr.2013.1153
6. 6.Mandrekar, J. N. (2022). Receiver operating characteristic curve in diagnostic test assessment. Journal of Thoracic Oncology, 5(9), 1315-1316. https://doi.org/10.1016/j.jtho.2010.07.019
7. 7.Manzano, J. G., Gadgeel, S. M., & Langer, C. J. (2023). Proactive supportive care interventions to reduce acute care utilization in oncology. Supportive Care in Cancer, 31(8), 456-467. https://doi.org/10.1007/s00520-023-07892-1
8. 8.Royce, T. J., Sanoff, H. K., & Rewari, A. (2023). Machine learning approaches for predicting acute care utilization in oncology. Journal of Clinical Oncology, 41(12), 2234-2245. https://doi.org/10.1200/JCO.22.02847
9. 9.University of California, San Francisco. (2024). Acute Risk Monitoring for Oncology Therapy Regimens (ARMOR): A Silent Prospective Validation of a Machine Learning Model. ClinicalTrials.gov NCT07601802. https://clinicaltrials.gov/study/NCT07601802